Hyasynth Bio: Funding, Investors & Team (Sep 2026)
Hyasynth Bio uses technologies from traditional and modern biology and combines computational analysis to develop the current drugs on the market used to treat nearly every disease known to humans. Hyasynth Bio specializes in producing these drugs, new targets, and using a quick and scalable platform based on engineered microbes.
Hyasynth Bio has raised $2.5M across 1 funding round on record, the most recent a Debt Financing of $2.5M announced in Dec 2021.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Hyasynth Bio Company Profile and Key Stats
Latest funding round on record: Dec 2021.
Hyasynth Bio Funding Rounds
Hyasynth Bio Founders and Leadership Team
No contact details are on record for this team yet.
Hyasynth Bio Funding Compared to Other Biotechnology Startups
Hyasynth Bio's latest round of $2.5M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Hyasynth Bio in Biotechnology and Montréal
Companies Similar to Hyasynth Bio
Medicenna is a clinical-stage immunotherapy company focused on oncology and the development and…
Cybin is a clinical-stage biopharmaceutical company on a mission to create safe and effective…
Hemostemix Inc. is a Canadian biotechnology company that specializes in creating blood-derived cell therapies…
Avicanna is an organization in the biopharmaceutical sector that concentrates on enhancing medical cannabis…
Edesa Biotech is a privately-held company in the clinical stage that specializes in creating therapies for…
ME Therapeutics is a biotech company that specializes in finding and creating drugs for immuno-oncology that…
Aurinia Pharmaceuticals is a clinical stage biopharmaceutical company focused on developing and…
Medicus Pharma is a biotechnology research company that fast-tracks the progress of life sciences and…
ProteinQure is a biotechnology company specializing in creating innovative peptides for various medical…
Anodyne's mission is to create critical chemicals sustainably. Anodyne's approach takes advantage of nature's…
NervGen Pharma is a medicine company dedicated to creating solutions for the treatment of nerve damage and…
ZYUS is a biopharmaceutical company focused on providing patients with cannabinoids and other plant-based…
Hyasynth Bio Funding FAQs
What does Hyasynth Bio do?
Hyasynth Bio uses technologies from traditional and modern biology and combines computational analysis to develop the current drugs on the market used to treat nearly every disease known to humans. Hyasynth Bio specializes in producing these drugs, new targets, and using a quick and scalable platform based on engineered microbes.
How much funding has Hyasynth Bio raised?
Hyasynth Bio has raised $2.5M across 1 round on record. The most recent is a Debt Financing of $2.5M announced in Dec 2021.
When did Hyasynth Bio last raise funding?
Hyasynth Bio's most recent funding round on record is a Debt Financing of $2.5M, announced in Dec 2021.
Who is the CEO of Hyasynth Bio?
Kevin Chen is listed as CEO at Hyasynth Bio.
Where is Hyasynth Bio headquartered?
Hyasynth Bio is based in Montréal, Quebec, Canada.
How many employees does Hyasynth Bio have?
Hyasynth Bio is in the 11-50 employee band.
How does Hyasynth Bio's funding compare to other Biotechnology startups?
Hyasynth Bio's latest round of $2.5M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Hyasynth Bio Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Hyasynth Bio is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.